Search

everythinglearnresearchcommunity

for

Search:↓

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Finasteride may increase the risk of suicidality and depression, especially in younger people.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Topical human epidermal growth factor may effectively treat acne caused by cancer medication.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Erlotinib can cause unusual hair growth, like long eyelashes and facial hair.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Asiasari radix extract may be a potential treatment for melanoma because it selectively triggers cell death in melanoma cells by affecting p53 regulation.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

5α-reductase inhibitors help treat prostate enlargement and hair loss but may cause side effects, requiring careful use.

5-alpha reductase inhibitors may reduce bladder cancer recurrence and improve survival.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.

Finasteride and dutasteride may cause macular abnormalities.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.